We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$930M
AUM Growth
+$23.6M
Cap. Flow
+$25.6M
Cap. Flow %
2.76%
Top 10 Hldgs %
25.89%
Holding
569
New
53
Increased
139
Reduced
144
Closed
48

Top Buys

Rank Stock Value
1
F icon
Ford
F
+$23.8M
2
RTN
Raytheon Company
RTN
+$23.7M
3
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
+$23.5M
4
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
+$23.4M
5
KMB icon
Kimberly-Clark
KMB
+$23.3M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$23.1M
2
AN icon
AutoNation
AN
+$22.7M
3
PEG icon
Public Service Enterprise Group
PEG
+$22.2M
4
PNW icon
Pinnacle West Capital
PNW
+$22.1M
5
AVGO icon
Broadcom
AVGO
+$22.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.56%
2 Communication Services 12.1%
3 Industrials 10.62%
4 Consumer Staples 10.55%
5 Materials 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBS icon
551
UBS Group
UBS
$170B
– –
-943,837
Closed -$19.7M
UNG icon
552
CALL
United States Natural Gas Fund
UNG
$470M
– –
-223
Closed -$617K
UNG icon
553
PUT
United States Natural Gas Fund
UNG
$470M
– –
-223
Closed -$554K
UNP icon
554
Union Pacific
UNP
$183B
– –
-185,361
Closed -$20.1M
VALE icon
555
Vale
VALE
$62.9B
– –
-553,263
Closed -$3.7M
VOD icon
556
Vodafone
VOD
$34.9B
– –
-3,930
Closed -$142K
VRSN icon
557
VeriSign
VRSN
$25.3B
– –
-11
Closed -$737
VRTX icon
558
Vertex Pharmaceuticals
VRTX
$121B
– –
-1,582
Closed -$187K
WEC icon
559
WEC Energy
WEC
$37.7B
– –
-438,756
Closed -$21.7M
XLI icon
560
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
– –
-2,688
Closed -$150K
XLK icon
561
State Street Technology Select Sector SPDR ETF
XLK
$115B
– –
-4,530
Closed -$93.9K
XLP icon
562
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
– –
-1,954
Closed -$95.2K
XRT icon
563
State Street SPDR S&P Retail ETF
XRT
$365M
– –
-3,052
Closed -$154K
BBBY
564
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-5,917
Closed -$454K
AGN
565
DELISTED
Allergan plc
AGN
– –
-74,025
Closed -$22M
LO
566
DELISTED
LORILLARD INC COM STK
LO
– –
-3,131
Closed -$205K
19 20 21 22
23

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q2 2015 Portfolio in Review

As of Q2 2015, Exane Derivatives held 569 positions worth $930M, up 2.6% from $906M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Exane Derivatives's Q2 2015 filing shows 53 new, 139 increased, 144 reduced and 48 closed positions. Its largest new stake was Raytheon Company: 225,989 shares worth $21.6M. The largest sale was Elevance Health, an estimated $23.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Communication Services and Industrials.

  • Exane Derivatives's largest Q2 2015 buy was Raytheon Company: 225,989 shares worth $21.6M.
  • Exane Derivatives added most to Ford in Q2 2015, an estimated $23.8M increase.
  • Exane Derivatives's biggest Q2 2015 reduction was Broadcom, cutting an estimated $22.1M.
  • Exane Derivatives fully exited Elevance Health in Q2 2015, selling an estimated $23.1M.
  • Exane Derivatives's ten largest holdings make up 26% of its $930M portfolio in Q2 2015.
  • Exane Derivatives opened 53 new positions and closed 48 in Q2 2015.
  • Exane Derivatives's portfolio value rose 2.6% quarter-over-quarter to $930M.

Based on Exane Derivatives's 13F filing for Q2 2015, filed 14 Aug 2015.